The maintenance of human CD4+CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro

International Immunology

Volumn 19, Issue 6, 2007, Pages 785-799

  Yates, John ^a   Rovis, Flavia ^a   Mitchell, Peter ^b   Afzali, Behdad ^b   Tsang, J Y S ^b   Garin, Marina ^b   Lechler, R I ^b   Lombardi, Giovanna ^b   Garden, O A ^a,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Common gamma chain; FOXP3; LY294002; Phosphatidylinositol 3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 7; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR FOXP3;

APOPTOSIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; APOPTOSIS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHROMONES; COCULTURE TECHNIQUES; CYCLOSPORINE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKIN-7; MORPHOLINES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES, REGULATORY;

EID: 34447574943     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm047     Document Type: Article

References (84)

1. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6:345.
2. Belkaid, Y. and Rouse, B. T. 2005. Natural regulatory T cells in infectious disease. Nat. Immunol. 6:353.
3. Tang, Q., Henriksen, K. J., Bi, M. et al. 2004. In vitro expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199:1455.
4. + regulatory T cells ex vivo. Blood 102:2180.
5. Asano, M., Toda, M., Sakaguchi, N. and Sakaguchi, S. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387.
6. Malek, T. R. and Bayer, A. L. 2004. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4:665.
7. Suzuki, H., Kundig, T. M., Furlonger, C. et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268:1472.
8. Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A. and Alt, F. W. 1995. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
9. Kramer, S., Schimpl, A. and Hunig, T. 1995. Immunopathology of interleukin (IL) 2-deficient mice: Thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J. Exp. Med. 182:1769.
10. + T cells. Eur. J. Immunol. 25:3053.
11. Klebb, G., Autenrieth, I. B., Haber, H. et al. 1996. Interleukin-2 is indispensable for development of immunological self-tolerance. Clin. Immunol. Immunopathol. 81:282.
12. Papiernik, M., de Moraes, M. L., Pontoux, C., Vasseur, F. and Penit, C. 1998. Regulatory CD4 T cells: Expression of IL-2R α chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10:371.
13. + T cells: Evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31:1637.
14. Malek, T. R., Yu, A., Vincek, V., Scibelli, P. and Kong, L. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17:167.
15. + T cell numbers. J. Immunol. 169:4850.
16. + T cells. Proc. Natl Acad. Sci. USA. 99:8832.
17. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201:723.
18. + T cells: A highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31:1122.
19. + T cell suppressor function. Eur. J. Immunol. 34:366.
20. + T cell suppressor function. J. Immunol. 172:6519.
21. + regulatory T cell function. Eur. J. Immunol. 34:2480.
22. + T cells for IL-2 and exploit it for the induction of IL-10 production. Int. Immunol. 17:279.
23. + regulatory T cell function. J. Exp. Med. 196:851.
24. Kovanen, P. E. and Leonard, W. J. 2004. Cytokines and immunodeficiency diseases: Critical roles of the γc-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev. 202:67.
25. Nelson, B. H. and Willerford, D. M. 1998. Biology of the interleukin-2 receptor. Adv. Immunol. 70:1.
26. Kovanen, P. E., Rosenwald, A., Fu, J. et al. 2003. Analysis of γc-family cytokine target genes. Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signaling. J. Biol. Chem. 278:5205.
27. + T cells that require antigen-specific activation for suppression. J. Immunol. 171:6431.
28. + regulatory T cells by peripheral expansion. J. Immunol. 173: 7259.
29. + regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. 171:3435.
30. high T cells in human STAT5b deficiency. J. Immunol. 177:2770.
31. reg cells fit. Nat. Immunol. 6:1071.
32. Fehervari, Z., Yamaguchi, T. and Sakaguchi, S. 2006. The dichotomous role of IL-2: Tolerance versus immunity. Trends Immunol. 27:109.
33. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. and Rudensky, A. Y. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6:1142.
34. + regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6:1152.
35. + regulatory T cell function. J. Autoimmun. 25:112.
36. + T regulatory cell-mediated suppression. J. Immunol. 174:7645.
37. + T-cells and is expressed by diabetes-suppressive dendritic cells. Diabetes 55:158.
38. + precursors. J. Immunol. 175:6107.
39. + suppressor T cells in vivo. Nat. Immunol. 3:33.
40. + immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311.
41. Kelly, E., Won, A., Refaeli, Y. and Van Parijs, L. 2002. IL-2 and related cytokines can promote T cell survival by activating AKT. J. Immunol. 168:597.
42. + regulatory T cells. J. Immunol. 172:5287.
43. + regulatory T cell lines from human cord blood have functional and molecular properties of T cell anergy. Blood 106:3068.
44. + T cells for self-T cell receptor determinants. J. Neurosci. Res. 76:129.
45. Matsuda, S., Shibasaki, F., Takehana, K., Mori, H., Nishida, E. and Koyasu, S. 2000. Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. EMBO Rep. 1:428.
46. Matsuda, S. and Koyasu, S. 2000. Mechanisms of action of cyclosporine. Immunopharmacology 47:119.
47. + immuno-regulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287.
48. Fujimoto, M., Tsutsui, H., Xinshou, O. et al. 2004. Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int. Immunol. 16:303.
49. Nakajima, H., Liu, X. W., Wynshaw-Boris, A. et al. 1997. An indirect effect of Stat5a in IL-2-induced proliferation: A critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction. Immunity 7:691.
50. Kim, H. P., Kelly, J. and Leonard, W. J. 2001. The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: Importance of two widely separated IL-2 response elements. Immunity 15:159.
51. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295.
52. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303.
53. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135.
54. Wang, X. B., Zheng, C. Y., Giscombe, R. and Lefvert, A. K. 2001. Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells. Scand. J. Immunol. 54:453.
55. + T cells expressing foxP3 in IL-2-treated HIV-infected patients. J. Clin. Invest. 115:1839.
56. + Tregs. J. Clin. Invest. 115:1953.
57. Perola, O., Ripatti, A. and Pelkonen, J. 2000. T-lymphocyte subpopulations do not express identical combinations of interleukin-2 receptor chains in the early phase of their activation and proliferation. Scand. J. Immunol. 52:123.
58. + T cells in thymus, cord and adult blood. Immunology 106:190.
59. high regulatory cells in human peripheral blood. J. Immunol. 167:1245.
60. + Treg cells. J. Exp. Med. 203:1701.
61. Seddiki, N., Santner-Nanan, B., Martinson, J. et al. 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203:1693.
62. Swainson, L., Verhoeyen, E., Cosset, F.-L. and Taylor, N. 2006. IL-7Rα gene expression is inversely correlated with cell cycle progression in IL-7-stimulated T lymphocytes. J. Immunol. 176:6702.
63. Schmitz, I., Krueger, A., Baumann, S., Schulze-Bergkamen, H., Krammer, P. H. and Kirchhoff, S. 2003. An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death. J. Immunol. 171:2930.
64. Waldmann, T. A., Dubois, S. and Tagaya, Y. 2001. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy. Immunity 14:105.
65. + memory T cells. J. Immunol. 171:5853.
66. Yagi, H., Nomura, T., Nakamura, K. et al. 2004. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol. 16:1643.
67. Mestas, J. and Hughes, C. C. 2004. Of mice and not men: Differences between mouse and human immunology. J. Immunol. 172:2731.
68. Lechler, R., Garden, O. and Turka, L. 2003. The complementary roles of deletion and regulation in transplantation tolerance. Nat. Rev. Immunol. 3:147.
69. Klein, L., Khazaie, K. and von Boehmer, H. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl Acad. Sci. USA 100:8886.
70. Antony, P. A., Paulos, C. M., Ahmadzadeh, M. et al. 2006. Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J. Immunol. 176:5255.
71. + regulatory T cells. Trends Immunol. 27:541.
72. Hartigan-O'Connor, D. J., Poon, C., Sinclair, E. and McCune, J. M. 2006. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods 319:41.
73. Zheng, Y., Manzotti, C. N., Liu, M., Burke, F., Mead, K. I. and Sansom, D. M. 2004. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 172:2778.
74. Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057.
75. + Tregs. J. Clin. Invest. 115:3276.
76. Gavin, M. A., Torgerson, T. R., Houston, E. et al. 2006. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl Acad. Sci. USA 103:6659.
77. + T cells. Eur. J. Immunol. 37:1.
78. + regulatory T cells through a STAT dependent mechanism and induces the expansion of these cells in vivo. Blood.
79. Ziegler, S. F. 2006. FOXP3: Of mice and men. Annu. Rev. Immunol. 24:209.
80. + Tregs. J. Clin. Invest. 116:2521.
81. Bondeva, T., Pirola, L., Bulgarelli-Leva, G., Rubio, I., Wetzker, R. and Wymann, M. P. 1998. Bifurcation of lipid and protein kinase signals of PI3Kgamma to the protein kinases PKB and MAPK. Science 282:293.
82. Lali, F. V., Crawley, J., McCulloch, D. A. and Foxwell, B. M. 2004. A late, prolonged activation of the phosphatidylinositol 3-kinase pathway is required for T cell proliferation. J. Immunol. 172:3527.
83. Moon, J. J., Rubio, E. D., Martino, A., Krumm, A. and Nelson, B. H. 2004. A permissive role for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor. J. Biol. Chem. 279:5520.
84. + T regulatory cells. Blood.